ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

Bob always said approval was needed! It's not easy getting CHina to open up and there is a lot of red tape. So now he's on record stating we have approval and the product is shipping in 2-3 weeks. Do you really think he would come on a radio interview and say that NOW just to say it if it wasn't so?

The next few months will tell us all we need to know. But the problem is one of credibility, where due to BS Schneiderman's history of issuing fluff PR's and failing to deliver on one forward-looking statement after another, the Street is clearly not willing to award SCRC hardly ANY speculative value into its sp whatsoever the way it does to many other startup companies. As a result, shareholders have been in a seemingly endless period of sp decline/stagnation while waiting for SCRC to prove its business model.

Case in point: BS Schneiderman issued this PR almost exactly a year ago last FEB-2014 where he infamously lied about the very RapiMed launch in Hong Kong that he is again touting in the stockradio.com interview released today. See relevant excerpt below:

ScripsAmerica's RapiMed Product Receives Registration Approval From the Hong Kong Government

Company's RapiMed(R) Children's Pain Reliever and Fever Reducer Can Now be Sold and Distributed Throughout Hong Kong
TYSONS CORNER, Va., Feb. 10, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has received registration approval for its RapiMed® Children's Pain Reliever & Fever Reducer from the Government of Hong Kong.

With the registration process complete, ScripsAmerica is now free to distribute RapiMed® throughout Hong Kong and the Company is ready to accept orders from affiliate hospital networks, and representatives of a major health product retailer with over 2,000 stores and over 500 pharmacies.

The header of the PR specifically states that regulatory approval has been obtained from Hong Kong back in FEB-2014. And the body of the PR clearly states that SCRC is now free to begin selling RapiMed in Hong Kong.

Pretty clear language in last year's PR, IMO...

...that being said, I actually believe BS Schneiderman this time that the regulatory approval has finally been attained in Hong Kong (not mainland China yet, mind you, but strictly just Hong Kong). Why? Two reasons: (1) I don't think that even BS Schneiderman is stupid enough to try to run this same con twice, and (2) Gregory FCA is a reputable IR firm and I do not believe that they would permit a client to tell outright lies under their watch. After all, Gregory FCA's reputation is on the line as well.

It is important to understand that in today's stockradio.com interview, all BS Schneiderman said was that RapiMed was only shipping to HK in order to get it into the hands of the distributor, GlobalPharmaHub. NO ACTUAL SALES have been made yet...

...HOWEVER, now that GPH will finally have physical tangible product in-hand to show potential customers, hopefully this will enable GPH to make effective pitches to the thousands of pharmacy/retail outlets to convince them to purchase RapiMed to stock on their store shelves. In fact, if GPH has been doing their job over the past year, they have already been cultivating relationships with the procurement officers at the major pharmacy/retail chains and have already provided them w/the product specs for RapiMeds -- in essence, everything a procurement officer needs to know in order to make a buy decision or not -- with the only holdup being proof that there is actually tangible product, which in a few weeks they will have in their hands, and be ready to make an immediate purchase from GPH.

Jury still out on this one, but getting physical product to HK is a MAJOR step in the right direction. Look forward to updates; hopefully a nice subsequent events disclosure will be included in either the 10K or the Q1 10Q to shed more light on this development.


Now, w/regards to the other discussion points from the stockradio.com interview, here are key points that I thought provided additional "missing pieces of the puzzle" in relation to prior points I had raised in the past:

(1)
PIMD expected to be PROFITABLE. I may be mistaken, but I thought that his specific wording implied that PIMD may be profitable as early as Q1'15. Did anyone else get this understanding? In any event, getting a statement specifically stating that PIMD is adding to the BOTTOM line and not simply the TOP line was good to hear.

(2)
Diabetic program expected to be PROFITABLE. Same comments/question as for PIMD above.

(3)
Diabetic supply seems to be strictly equip/supplies only and NOT including the actual meds (surprising as Main Ave IS a pharmacy after all and could easily fill the Rx's as well). Anyone else get this impression or has there been something communicated that leads us to believe that Main Ave is also filling the Rx meds in addition to providing the supplies/equip?

(4)
THE BEST NEWS FOR SHAREHOLDERS: Going forward, straight debt financing in lieu of BOTH convert note financing AND equity financing.

Thank goodness the issuance of new shares is being kept to a minimum. Now we just need to continue flushing thru the remaining overhang of discounted stock. Once most is gone, the sp should be able to more naturally begin getting more and more in-sync w/company operational fundamentals.


*******************

all of the performance indicators for ScripsAmerica are pointing North. There isn't one revenue stream performing in the negative. With money in the bank, funding from a reputable institution, several profitable revenue streams, and a new IR Team on board, SCRC and Mr. Schneiderman are proving the business model he created two years ago is real and is working. The future is very promising. Now I know there are still those who have doubts, and that's okay. I am confident their concerns will be resolved in the months to come. Yes, it's been a long two years, but it is all coming together now.

@Guts,
This is actually a very fair post.

I think it is important to distinguish the "investors" from the "speculators". Both are segments of retail (as well as TUTs, in particular more HF's are willing to speculate while most traditional TUTs -- such as pension plans, funds, etc, have little appetite for risk and only seek to "invest" in solid companies).

And why is this distinction between speculators and investors important if both are longs?

Because speculative longs are willing to take greater risk and jump in before the business model has been sufficiently proven. Investor-type longs are willing to pay a premium in order to minimize/eliminate risk.

And, as I am sure you will agree, we have seen many types of both dip their toes into SCRC over the past couple of years, as evidenced by the types of questions they ask as they perform their own DD on the company/stock.

BUT, regardless of whether one is a speculator or investor, the one common ground that they share is that it is important to be cognizant of what constitutes a proper entry point. And to this end -- IN SPITE OF THE FACT THAT SCRC HAS ALWAYS SHOWN POTENTIAL -- there really has been zero reason for ANY long (trading longs are a compeltely different story, though, LOL, but I am strictly talking about true longs right now) to buy in over the past 2 years prior to Q4'14.

Why? Dilution, plain and simple. Dilution is the number 1 killer of sp's for almost evey single micro-/small-cap company, bar none. And SCRC's own SEC filings disclosed in bold plain English since Q2'13 that there was unprecedented levels of dilution coming our way that would take at least a year to flush thru.

And the historical tape has clearly proven this beartrap to be true as the sp has essentially done nothing other than crater down to historical lows of .08x time and time again as wave after wave of dilution hit the float -- with the primary culprit being the 28M shares of the 0.00 and 0.05 PIPE stock held primarily by JOSEPH ZAMPETTI and his "inner cicle" (LOL!) of fellow non-disclosing Section 17(b)-violating promoters.

In fact, if one were to go thru the archives of all the touts put forth into the public space across all the numerous platforms, one would notice one glaring pattern: 99.9% of the calls to "BUY NOW!" and "HOLD AND ADD BUT DON'T SELL OR TRADE!" and "MOON SHOT IMMINENT!" and "MOTHER OF ALL CATALYSTS COMING!" were made by JOSEPH ZAMPETTI and his horde of associates who also held tranches of the 28M shares of 0.00 and 0.05 PIPE stock and needed to consistently try to drum up bid support because they knew that it would take a long time to liquidate 28M shares. And the calls to buy/add/hold are continuing to this day even though they know full that there is still substantial dilution waiting to flush thru the overhang.

The dilution picture is much improved currently, but JOEY Z and his gang of crooks still have millions of shares of toxic .05 PIPE stock they are trying to unload, and there are still financier shares lurking in the overhang waiting to be sold once the sp rises to satisfactory levels.

I have been asked for an updated "Dilution Update" analysis, which I will post in a couple days, which will show a ballpark estimate of how much dilution still remains in the overhang.